Home Page
BEIJING--November 24, 2021--Researched by Industrial Info Resources (Sugar Land, Texas)--Pharmaceutical company CARsgen Therapeutics Holdings Limited (Xuhui, China) recently joined European Medicines Agency's (EMA) PRIME (Priority Medicine) plan for its CAR-T Therapy product CT041, which is used to treat solid tumors.
(All Fields Required)
Site-wide Scheduled Maintenance for September 27, 2025 from 12 P.M. to 6 P.M. CDT. Expect intermittent web site availability during this time period.
×Contact Us
For More Info!
